The effect of chronic conditions on stated preferences for health

European Journal of Health Economics

Volumn 14, Issue 4, 2013, Pages 697-702

  Pickard, A Simon ^a   Tawk, Rima ^a   Shaw, James W ^a,b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b ABBOTT LABORATORIES   (United States)

Author keywords

EQ 5D; Health status; Illness; Utility; Valuation

Indexed keywords

ADULT; AGED; ARTHRITIS; ARTICLE; CANCER PATIENT; CHRONIC DISEASE; DEPRESSION; DIABETES MELLITUS; FEMALE; HAY FEVER; HEALTH; HEALTH STATUS; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MARRIAGE; NEOPLASM; PATIENT PREFERENCE; PRIORITY JOURNAL; RACE;

ADULT; AGED; ARTHRITIS; ATTITUDE TO HEALTH; CHRONIC DISEASE; DEPRESSION; DIABETES MELLITUS; FEMALE; HEALTH STATUS; HEART FAILURE; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PATIENT PREFERENCE; QUALITY OF LIFE; QUESTIONNAIRES; RHINITIS, ALLERGIC, SEASONAL; UNITED STATES;

EID: 84879949512     PISSN: 16187598     EISSN: 16187601     Source Type: Journal    
DOI: 10.1007/s10198-012-0421-8     Document Type: Article

References (21)

1. Boyd, N.F.; Sutherland, H.J.; Heasman, K.Z.; Tritchler, D.L.; Cummings, B.J.: Whose utilities for decision analysis? Med. Decis. Mak. 10(1), 58-67 (1990)
2. Chapman, B.P.; Franks, P.; Duberstein, P.R.; Jerant, A.: Differences between individual and societal health state valuations: any link with personality? Med. Care 47(8), 902-907 (2009)
3. Ubel, P.A.; Loewenstein, G.; Hershey, J.; Baron, J.; Mohr, T.; Asch, D.A.; Jepson, C.: Do nonpatients underestimate the quality of life associated with chronic health conditions because of a focusing illusion? Med. Decis. Mak. 21(3), 190-199 (2001)
4. Ubel, P.A.; Richardson, J.; Menzel, P.: Societal value, the person trade-off, and the dilemma of whose values to measure for cost-effectiveness analysis. Health Econ. 9(2), 127-136 (2000)
5. Dobrez, D.; Cella, D.; Pickard, A.S.; Lai, J.S.; Nickolov, A.: Estimation of patient preference-based utility weights from the functional assessment of cancer therapy - general. Value Health 10(4), 266-272 (2007)
6. Boye, K.S.; Matza, L.S.; Walter, K.N.; Van Brunt, K.; Palsgrove, A.C.; Tynan, A.: Utilities and disutilities for attributes of injectable treatments for type 2 diabetes. Eur. J. Health Econ. 12(3), 219-230 (2011)
7. Revicki, D.; Margolis, M.; Thompson, C.; Meltzer, E.; Sandor, D.; Shaw, J.: Major symptom score utility index for patients with acute rhinosinusitis. Am.J. Rhinol. Allergy 25(3), 99-106 (2011)
8. Pickard, A.S.; Knight, S.J.: Proxy evaluation of health-related quality of life: a conceptual framework for understanding multiple proxy perspectives. Med. Care 43(5), 493-499 (2005)
9. Sneeuw, K.C.; Sprangers, M.A.; Aaronson, N.K.: The role of health care providers and significant others in evaluating the quality of life of patients with chronic disease. J. Clin. Epidemiol. 55(11), 1130-1143 (2002)
10. Dolan, P.: The effect of experience of illness on health state valuations. J. Clin. Epidemiol. 49(5), 551-564 (1996)
11. Kind, P.; Dolan, P.: The effect of past and present illness experience on the valuations of health states. Med. Care 33(Suppl 4), AS255-AS263 (1995)
12. Krabbe, P.F.; Tromp, N.; Ruers, T.J.; van Riel, P.L.: Are patients' judgments of health status really different from the general population? Health Qual. Life Outcomes 9, 31 (2011)
13. Postulart, D.; Adang, E.M.: Response shift and adaptation in chronically ill patients. Med. Decis. Mak. 20(2), 186-193 (2000)
14. Ubel, P.A.; Loewenstein, G.; Schwarz, N.; Smith, D.: Misimagining the unimaginable: the disability paradox and health care decision making. Health Psychol. 24(4 Suppl), S57-S62 (2005)
15. Albrecht, G.L.; Devlieger, P.J.: The disability paradox: high quality of life against all odds. Soc. Sci. Med. 48(8), 977-988 (1999)
16. Shaw, J.; Johnson, J.; Chen, S.; Levin, J.; Coons, S.: Racial/ethnic differences in preferences for the EQ-5D health states: results from the U.S. valuation study. J. Clin. Epidemiol. 60(5), 479-490 (2007)
17. Rabin, R.; de Charro, F.: EQ-5D: a measure of health status from the EuroQol Group. Ann. Med. 33(5), 337-343 (2001)
18. Shaw, J.W.; Johnson, J.A.; Coons, S.J.: US valuation of the EQ-5D health states: development and testing of the D1 valuation model. Med. Care 43(3), 203-220 (2005)
19. Pickard, A.S.; Neary, M.P.; Cella, D.: Estimation of minimally important differences in EQ-5D utility and VAS scores in cancer. Health Qual. Life Outcomes 5, 70 (2007)
20. Luo, N.; Johnson, J.; Coons, S.J.: Using instrument-defined health state transitions to estimate minimally important differences for four preference-based health-related quality of life instruments. Med. Care 48(4), 365-371 (2010)
21. Kahneman, D.; Tversky, A.: Prospect theory: an analysis of decision under risk. Econometrica 47(2), 263-292 (1979)